ALKS

Alkermes plc Ordinary Shares

HealthcareDrug Manufacturers - Specialty & GenericIrelandNASDAQ

$35.26

-2.73%today

MKT CAP

$5.9B

+3.4% · 1Y

Full Financials

Trailing P/E39.3x

Forward P/E22.7x

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ+2.2%

5y Revenue CAGR+9.9%

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership1.4%

Institutional Ownership111.0%

Short % of Float16.46%

Days to Cover6.8d

1 Week+3.9%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
LNTH Lantheus Holdings Inc. Common Stock	$5.6B	62	25.3	13.7	-	-	-	-	0.00%
HIMS Hims & Hers Health Inc. Class A Common Stock	$6.2B	48	50.3	18.6	36.4	25.2%	74%	207.16	0.00%
INDV Indivior Pharmaceuticals Inc. Common Stock	$4.8B	71	20.8	10.4	-	-	-	-	0.00%
KNSA Kiniksa Pharmaceuticals International plc Class A Ordinary Shares	$4.4B	13	62.4	32.3	-	-	-	-	0.00%
AMRX Amneal Pharmaceuticals Inc. Class A Common Stock	$4.4B	47	62.4	11.6	-	-	-	-	0.00%
LQDA Liquidia Corporation Common Stock	$3.7B	63	-	8.1	-	-111.1%	92%	442.31	0.00%